These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD]. Glaab T; Weiss T Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. Sirak TE; Jelic S; Le Jemtel TH J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010 [TBL] [Abstract][Full Text] [Related]
7. Beta-blocker underuse in secondary prevention of myocardial infarction. Everly MJ; Heaton PC; Cluxton RJ Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. Chen J; Radford MJ; Wang Y; Marciniak TA; Krumholz HM J Am Coll Cardiol; 2001 Jun; 37(7):1950-6. PubMed ID: 11401137 [TBL] [Abstract][Full Text] [Related]
9. [Differential therapy with beta blockers. What is their value, what are the risks?]. Bäumer AT; Erdmann E MMW Fortschr Med; 2001 Sep; 143(39):36-8. PubMed ID: 11680926 [TBL] [Abstract][Full Text] [Related]
10. Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment. Lama PJ Am J Ophthalmol; 2002 Nov; 134(5):749-60. PubMed ID: 12429254 [TBL] [Abstract][Full Text] [Related]
11. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists. Hawkins NM; Petrie MC; Macdonald MR; Jhund PS; Fabbri LM; Wikstrand J; McMurray JJ J Am Coll Cardiol; 2011 May; 57(21):2127-38. PubMed ID: 21596228 [TBL] [Abstract][Full Text] [Related]
12. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy. Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)]. Lemmer B Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492 [TBL] [Abstract][Full Text] [Related]
14. [Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease]. Karoli NA; Rebrov AP Kardiologiia; 2021 Oct; 61(10):89-98. PubMed ID: 34763643 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ; Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710 [TBL] [Abstract][Full Text] [Related]
16. [Beta receptor blockers in patients with obstructive respiratory diseases -- risks and alternatives]. Worth H Pneumologie; 2005 Dec; 59(12):858-61. PubMed ID: 16379054 [TBL] [Abstract][Full Text] [Related]
17. beta-Adrenoceptor blockade and pulmonary function in patients suffering from chronic obstructive lung disease. van Herwaarden CL J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S46-50. PubMed ID: 6188919 [TBL] [Abstract][Full Text] [Related]